Frontlight ResearchEarly access
Trial site
Mass General Cancer Center
- 4running trials
- 4closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Colorectal cancer2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Liver and biliary tract cancer1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Pancreatic cancer1 trial
- Prostate cancer1 trial
- and 3 more
- Phase
- Phase 14 trials
- Phase 23 trials
- Phase 31 trial
- Status
- Completed4 trials
- Recruiting2 trials
- Active, not recruiting1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Bayer2 trials
- Eli Lilly and Company1 trial
- Flare Therapeutics Inc.1 trial
- Incendia Therapeutics1 trial
- Novo Nordisk A/S1 trial
- and 2 more
Running trials
Recruiting
Recruiting
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Cervical cancer1 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Completed
Completed
Completed
Research Study Investigating How Well NDec Works in People With Sickle Cell Disease
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026